CH 9- Hematopoietic System Lecture Flashcards

Introduction to the Hematopoietic System and Blood Physiology

  • Definition of the Hematopoietic System: This system is responsible for the continuous production of blood cells, a process known as hematopoiesis.

  • General Function: It ensures the body maintains an adequate number of red blood cells, white blood cells, and platelets. This maintenance is critical for oxygen transport, immune defense, and hemostasis (blood clotting) throughout a person's life.

  • The Three Main Cellular Components:

    • Erythrocytes (Red Blood Cells): Primary agents of oxygen transport.

    • Leukocytes (White Blood Cells): Components of the immune system that fight infection.

    • Thrombocytes (Platelets): Facilitate blood clotting following injury or trauma.

Blood Composition and Components

  • Physical Composition: Blood consists of cells suspended in plasma, which is the liquid portion of the blood.

  • Functions of Blood: Transports gases, nutrients, waste, hormones, heat, and immune cells throughout the entire body.

  • Proportional Composition:

    • Plasma: Makes up approximately 55%55\% of blood volume.

    • Formed Elements: Make up approximately 45%45\% of blood volume (Erythrocytes, Leukocytes, and Thrombocytes).

  • Erythrocyte Characteristics and Production:

    • Formation Sites: Formed in red bone marrow found in the vertebrae, proximal femurs, and flat bones (sternum, ribs, skull, and pelvis).

    • Structure: Biconcave discs (indented in the middle). This shape maximizes surface area for gas exchange and allows flexibility to navigate tiny capillaries and vessel branches.

    • Hemoglobin: An iron-based protein packed within red blood cells that carries oxygen from the respiratory tract to bodily tissues.

    • Function: Transporting oxygen to tissues and carrying carbon dioxide back to the lungs.

    • Lifespan: Approximately 120120 days. After this, they are removed by the spleen and liver to be broken down, and the hemoglobin is recycled.

  • Leukocyte Characteristics and Classification:

    • Formation Sites: Red bone marrow and lymphoid tissue.

    • Function: Provide immunity and defense against pathogens, cellular debris, and abnormal cells.

    • Granulocytes:

      • Neutrophils: The most abundant white blood cell and first responders to infection; they perform phagocytosis (engulfing bacteria).

      • Eosinophils: Involved in parasitic defense and allergic responses.

      • Basophils: Release histamine (involved in allergies) and heparin (an anticoagulant); they participate in inflammation.

    • Agranulocytes:

      • Lymphocytes: Classified into B cells (antibody production), T cells (cell-mediated immunity), and Natural Killer (NK) cells (destroying abnormal cells).

      • Monocytes: Differentiate into macrophages that perform phagocytosis and antigen presentation.

  • Platelets (Thrombocytes):

    • Formation Site: Red bone marrow.

    • Function: Adhere to damaged vessels and aggregate to form temporary plugs and clots while releasing chemicals to activate clotting factors.

  • Plasma Detailed Composition:

    • Primarily water with dissolved substances.

    • Proteins: Albumin (maintains osmotic pressure), Globulins (includes antibodies), and Fibrinogen (essential for clot formation).

    • Electrolytes: Sodium, potassium, calcium, chloride, and bicarbonate.

    • Nutrients: Glucose, amino acids, and lipids.

    • Waste Products: Urea (formed by muscle metabolism) and creatinine (found in the kidneys).

Hemostasis, Coagulation, and Blood Typing

  • Hemostasis and Coagulation:

    • Hemostasis: The prevention of blood loss while maintaining circulation.

    • Coagulation Cascade: A complex series of enzymatic reactions involving clotting factors produced in the liver. This process requires calcium and Vitamin K.

    • Mechanism: Converts fibrinogen into fibrin. Once healing occurs, the clot is dissolved via fibrinolysis.

  • Blood Group Systems:

    • ABO System: Determined by antigens on red blood cell membranes. Plasma contains antibodies against absent antigens.

    • Agglutination: An immune reaction where cells clump together after being bound by antibodies; occurs during incompatible transfusions.

    • Rh Factor: Determines if a patient is Rh-positive (antigen present) or Rh-negative (antigen absent). This is critical in pregnancy.

  • Antigens: Molecular structures recognized as either "self" or "non-self" that can trigger immune responses.

  • Hematopoiesis Regulation: Controlled by a feedback mechanism involving the brain and endocrine system to adjust production based on blood levels.

  • Acid-Base Balance: Blood acts as a buffer to maintain proper pH levels.

Anemia: General Overview and Systems

  • Definition: Characterized by a reduction in the oxygen-carrying capacity of the blood, with hemoglobin levels below normal ranges based on age and sex.

  • Nature of Anemia: It is not a disease itself but a sign of an underlying physiologic or pathologic process (e.g., cancer, diet, blood loss).

  • General Symptoms:

    • Fatigue and weakness (most common).

    • Pallor (pale skin, mucous membranes, nail beds, and conjunctiva).

    • Dyspnea (shortness of breath during exertion).

    • Tachycardia and palpitations (compensatory mechanism where the heart pumps faster to deliver limited oxygen).

    • Dizziness, lightheadedness, syncope, and exercise intolerance.

Iron Deficiency Anemia

  • Epidemiology: The most common type of anemia worldwide.

  • Etiology:

    • Inadequate iron intake (poor diet, malnutrition, vegetarianism without supplementation).

    • Inadequate iron absorption (celiac disease, Crohn's/IBD, gastric surgery/bypass).

    • Chronic blood loss (GI bleeding, heavy menstruation, frequent blood donations).

    • Increased demand (pregnancy, childhood growth, endurance training).

  • Pathophysiology: Results in microcytic hypochromic red blood cells (small and pale) due to impaired hemoglobin synthesis.

  • Specific Clinical Manifestations:

    • Koilonychia: Spoon-shaped nails.

    • Glossitis: Smooth, inflamed, sore red tongue.

    • Angular Cheilitis: Cracking and soreness at the corners of the mouth.

    • Pica: Abnormal cravings for non-nutritive substances like ice, clay, dirt, or starch.

  • Clinical Significance: Often the first sign of an occult (hidden) disease or bleeding.

  • Lab Findings: Decreased hemoglobin, hematocrit, red blood cell count, and serum iron. Decreased ferritin (iron stored in the liver/spleen) is the most sensitive indicator.

  • Treatment: Oral iron supplementation (first line), dietary changes, or IV iron for severe cases.

Hemolytic Anemia and Genetic Variants

  • Definition: A group of anemias characterized by the premature destruction of red blood cells (hemolysis) where the destruction rate exceeds the bone marrow's production capability.

  • Morphology: Usually normocytic (normal size and color).

  • Classifications:

    • Intrinsic (Hereditary): Defects within the red blood cell itself (e.g., Hereditary Spherocytosis, Sickle Cell Anemia).

    • Extrinsic (Acquired): Normal cells destroyed by external factors (e.g., Autoimmune Hemolytic Anemia, Erythroblastosis Fetalis).

  • Specific Symptoms: Jaundice (yellowing of skin/mucosa), dark urine, enlarged spleen, and gallstones (due to elevated bilirubin).

  • Hereditary Spherocytosis:

    • Mechanism: Defects in membrane proteins produce rigid, spherical cells (spherocytes) rather than biconcave discs.

    • Impact: Spleen identifies them as abnormal and destroys them. Most common in Northern European descendants.

    • Aplastic Crisis: A sudden temporary shutdown of red blood cell production.

    • Treatment: Folic acid and potential splenectomy (often delayed until age 33 to allow immune system development).

  • Sickle Cell Anemia:

    • Mechanism: Inherited autosomal recessive disorder involving abnormal hemoglobin.

    • Morphology: Rigid, crescent-shaped (sickle) cells.

    • Impact: Shortened lifespan (1010 to 2020 days). Cells get trapped, causing vaso-occlusive crisis (severe bone/muscle pain). More common in African descent

    • Specific Manifestations: Dactylitis (sausage-shaped fingers/toes in children), asplenia (non-functional spleen), acute chest syndrome, and stroke risk.

    • Management: Hydroxyurea (to increase fetal hemoglobin), pain management, and transcranial Doppler ultrasound for stroke screening.

  • Thalassemia:

    • Population: Common in Mediterranean ancestry.

    • Pathophysiology: Ineffective erythropoiesis and abnormal hemoglobin synthesis. Cells are microcytic and hypochromic.

    • Imaging Findings: "Crew cut" or "hair on end" appearance of the skull on X-ray; "chipmunk face" due to maxillary overgrowth.

    • Complications: Iron overload (from frequent transfusions).

Immune-Mediated and Nutritional Anemias

  • Autoimmune Hemolytic Anemia:

    • Acquired/Extrinsic; immune system produces antibodies against its own red blood cells.

    • Symptoms: Acrocyanosis (blue tint to fingers/ears) and Raynaud-like symptoms.

    • Diagnosis: Positive Direct Antiglobulin Test (Coombs test).

  • Erythroblastosis Fetalis (Hemolytic Disease of the Newborn):

    • Mechanism: Maternal antibodies cross the placenta and destroy fetal red blood cells due to blood group incompatibility.

    • Rh Incompatibility: Occurs with an Rh-negative mother and Rh-positive fetus. Affects subsequent pregnancies after sensitization.

    • ABO Incompatibility: Affects first pregnancy but is usually milder.

    • Severe Outcome: Hydrops fetalis (generalized edema, ascites, heart failure, and possible fetal death).

    • Prevention: RhoGAM (Rh immunoglobulin) given at 2828 weeks gestation and within 7272 hours postpartum.

  • Megaloblastic Anemia:

    • Caused by impaired DNA synthesis due to Vitamin B12B_{12} or Folate (B9B_9) deficiency.

    • Morphology: Abnormally large immature precursors (megaloblasts).

    • Pernicious Anemia: An autoimmune form of B12B_{12} deficiency caused by lack of intrinsic factor (secreted by gastric parietal cells) needed for absorption in the terminal ileum.

    • Neurologic Effects: B12B_{12} deficiency can cause irreversible peripheral neuropathy and gait disturbances.

Bone Marrow Disorders and Polycythemia

  • Aplastic Anemia:

    • Bone marrow failure leading to pancytopenia (low red cells, white cells, and platelets).

    • Not a destruction of cells, but a failure of production.

    • Biopsy Finding: Replacement of bone marrow with fat.

  • Myelophthisic Anemia:

    • Bone marrow "wasting" or infiltration by abnormal tissue, typically metastatic cancer.

    • Leads to extramedullary hematopoiesis (the liver and spleen try to produce blood), causing hepatosplenomegaly.

  • Polycythemia Vera (Primary Polycythemia):

    • A chronic myeloproliferative neoplasm involving overproduction of red blood cells independent of normal regulation.

    • Impact: Increased blood viscosity (thickness), leading to high risk of thrombosis (DVT, stroke, MI).

    • Symptoms: Headaches, dizziness, facial plethora (ruddy complexion), and pruritus (itching) after warm bathing.

    • Treatment: Phlebotomy (bloodletting) to maintain hematocrit less than 45%45\%.

  • Secondary Polycythemia: Increased red cell mass as a response to hypoxia (e.g., in COPD) or inappropriate erythropoietin secretion.

Leukemias and Lymphomas

  • Leukemia: Malignant proliferation of abnormal white blood cell precursors in bone marrow.

  • Major Classifications:

    • AML (Acute Myelogenous): Aggressive; common in adults over 6060.

    • ALL (Acute Lymphoblastic): Most common childhood leukemia; aggressive but often curable in children.

    • CML (Chronic Myelogenous): Characterized by the Philadelphia chromosome; can progress to a terminal "blast crisis."

    • CLL (Chronic Lymphocytic): Most common leukemia in Western adults (median age 7070); slow-growing (indolent).

  • Leukostasis: A life-threatening emergency in acute leukemia where extremely high white cell counts obstruct small vessels.

  • Lymphoma: Malignant solid tumors of lymphoid tissue (B cells, T cells, or NK cells).

  • Hodgkin Lymphoma:

    • Marked by Reed-Sternberg cells.

    • Often follows an orderly spread and is highly treatable.

  • Non-Hodgkin Lymphoma:

    • More heterogeneous and spreads in a non-contiguous manner.

  • Clinical Signs of Lymphoma: Painless lymphadenopathy (firm/rubbery nodes), and "B Symptoms" (unexplained fever, night sweats, weight loss).

  • Infectious Mononucleosis (Mono):

    • Acute viral infection caused by the Epstein-Barr Virus (EBV).

    • Known as the "kissing disease" due to transmission via saliva.

    • Classic Triad: Fever, pharyngitis, and lymphadenopathy.

    • Precaution: Avoid contact sports for 33 to 44 weeks to prevent splenic rupture due to splenomegaly.

Bleeding and Platelet Disorders

  • Hemophilia: Inherited X-linked recessive bleeding disorders affecting primarily males.

    • Type A: Deficiency of Factor VIIIVIII (most common, 85%85\% of cases).

    • Type B (Christmas Disease): Deficiency of Factor IXIX.

    • Type C: Deficiency of Factor XIXI (rare, autosomal recessive, affects both sexes).

    • Clinical sign: Hemarthrosis (bleeding into joints).

  • Purpura: Purple skin discoloration from bleeding into skin/mucosa.

  • Thrombocytopenia: Low platelet count usually leading to skin/mucosal bleeding (petechiae and purpura).

  • Immune Thrombocytopenia (ITP): Acquired autoimmune destruction of platelets.

    • Acute: Common in children following a viral infection; self-limiting.

    • Chronic: Common in adults; requires long-term management.